Stephen J Nicholls

Navedeno

	Vse	Od leta 2019
Navedbe	60197	32911
indeks h	104	74
indeks i10	394	319

8000

4000

2000

6000

2006200720082009201020112012201320142015201620172018201920202021202220232024397 827 1379 1590 1558 1785 1965 2309 2620 2680 2965 3089 3198 3281 4165 6076 7348 7996 3745

Javni dostop

Prikaži vse

167 člankov

48 člankov

na voljo

ni na voljo

Na podlagi zahtev v povezavi s financiranjem

Soavtorji

Rishi PuriCardiovascular Medicine, Cleveland ClinicPreverjeni e-poštni naslov na ccf.org
Philip BarterUnivrsity of New South Wales AustraliaPreverjeni e-poštni naslov na unsw.edu.au
Christie BallantyneBaylor College of MedicinePreverjeni e-poštni naslov na bcm.edu
Paul SchoenhagenProfessor of Radiology, Cleveland ClinicPreverjeni e-poštni naslov na ccf.org
A. Michael LincoffProfessor of Medicine, Cleveland ClinicPreverjeni e-poštni naslov na ccf.org
Ilke SipahiProf. Dr. ILKE SIPAHI MuayenehanesiPreverjeni e-poštni naslov na ilkesipahi.com
Peter PsaltisSouth Australian Health and Medical Research InstitutePreverjeni e-poštni naslov na sahmri.com
Kausik Kumar RayProfessor of Public Health, Imperial College LondonPreverjeni e-poštni naslov na imperial.ac.uk
Stanley L HazenCleveland ClinicPreverjeni e-poštni naslov na ccf.org
Peter LibbyProfessor of Medcine Harvard Medical SchoolPreverjeni e-poštni naslov na bwh.harvard.edu
Adam J NelsonCALHN | UofA | VHI | DCRIPreverjeni e-poštni naslov na adelaide.edu.au
Christina BursillThe University of AdelaidePreverjeni e-poštni naslov na sahmri.com
John CHAPMANSorbonne University and Pitie-Salpetriere University HospitalPreverjeni e-poštni naslov na upmc.fr
Kerry-Anne RyeUniversity of New South WalesPreverjeni e-poštni naslov na unsw.edu.au
Belinda Di BartoloThe University of SydneyPreverjeni e-poštni naslov na sydney.edu.au
Matthew WorthleyAssociate Professor, University of AdelaidePreverjeni e-poštni naslov na adelaide.edu.au
John BeltrameProfessor of Medicine - Michell Chair, University of AdelaidePreverjeni e-poštni naslov na adelaide.edu.au
Gemma FigtreeProfessor, Sydney Medical School (Northern), University of SydneyPreverjeni e-poštni naslov na sydney.edu.au
celermajerprofessor of cardiology, university of sydneyPreverjeni e-poštni naslov na email.cs.nsw.gov.au
Maciej BanachSecretary, European Atherosclerosis Society & President, International Lipid Expert Panel; PolandPreverjeni e-poštni naslov na umed.lodz.pl

Spremljaj

Stephen J Nicholls

Monash University

Preverjeni e-poštni naslov na monash.edu


Naslov Razvrsti po navedbah Razvrsti po letniku Razvrsti po naslovu	Navedeno Navedeno	Leto
Cardiovascular and renal outcomes with empagliflozin in heart failure M Packer, SD Anker, J Butler, G Filippatos, SJ Pocock, P Carson, ... New England Journal of Medicine 383 (15), 1413-1424, 2020	3943	2020
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European … BA Ference, HN Ginsberg, I Graham, KK Ray, CJ Packard, E Bruckert, ... European heart journal 38 (32), 2459-2472, 2017	3291	2017
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial SE Nissen, SJ Nicholls, I Sipahi, P Libby, JS Raichlen, CM Ballantyne, ... Jama 295 (13), 1556-1565, 2006	3015	2006
Empagliflozin in heart failure with a preserved ejection fraction SD Anker, J Butler, G Filippatos, JP Ferreira, E Bocchi, M Böhm, ... New England Journal of Medicine 385 (16), 1451-1461, 2021	2977	2021
Effects of dalcetrapib in patients with a recent acute coronary syndrome GG Schwartz, AG Olsson, M Abt, CM Ballantyne, PJ Barter, J Brumm, ... New England Journal of Medicine 367 (22), 2089-2099, 2012	2268	2012
Antiinflammatory properties of HDL PJ Barter, S Nicholls, KA Rye, GM Anantharamaiah, M Navab, ... Circulation research 95 (8), 764-772, 2004	1698	2004
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials AM Lincoff, K Wolski, SJ Nicholls, SE Nissen Jama 298 (10), 1180-1188, 2007	1660	2007
Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis M Jun, C Foote, J Lv, B Neal, A Patel, SJ Nicholls, DE Grobbee, A Cass, ... The Lancet 375 (9729), 1875-1884, 2010	1198	2010
Effect of torcetrapib on the progression of coronary atherosclerosis SE Nissen, JC Tardif, SJ Nicholls, JH Revkin, CL Shear, WT Duggan, ... New England Journal of Medicine 356 (13), 1304-1316, 2007	1165	2007
Effect of evolocumab on progression of coronary disease in statin-treated patients: the GLAGOV randomized clinical trial SJ Nicholls, R Puri, T Anderson, CM Ballantyne, L Cho, JJP Kastelein, ... Jama 316 (22), 2373-2384, 2016	1107	2016
Effect of two intensive statin regimens on progression of coronary disease SJ Nicholls, CM Ballantyne, PJ Barter, MJ Chapman, RM Erbel, P Libby, ... New England Journal of Medicine 365 (22), 2078-2087, 2011	1107	2011
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European … J Boren, MJ Chapman, RM Krauss, CJ Packard, JF Bentzon, CJ Binder, ... European heart journal 41 (24), 2313-2330, 2020	1080	2020
Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial SE Nissen, SJ Nicholls, K Wolski, R Nesto, S Kupfer, A Perez, H Jure, ... Jama 299 (13), 1561-1573, 2008	1012	2008
Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis SJ Nicholls, EM Tuzcu, I Sipahi, AW Grasso, P Schoenhagen, T Hu, ... Jama 297 (5), 499-508, 2007	979	2007
Myeloperoxidase and cardiovascular disease SJ Nicholls, SL Hazen Arteriosclerosis, thrombosis, and vascular biology 25 (6), 1102-1111, 2005	966	2005
Protein carbamylation links inflammation, smoking, uremia and atherogenesis Z Wang, SJ Nicholls, ER Rodriguez, O Kummu, S Hörkkö, J Barnard, ... Nature medicine 13 (10), 1176-1184, 2007	791	2007
Evacetrapib and cardiovascular outcomes in high-risk vascular disease AM Lincoff, SJ Nicholls, JS Riesmeyer, PJ Barter, HB Brewer, KAA Fox, ... New England Journal of Medicine 376 (20), 1933-1942, 2017	737	2017
Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: the STRENGTH randomized clinical trial SJ Nicholls, AM Lincoff, M Garcia, D Bash, CM Ballantyne, PJ Barter, ... Jama 324 (22), 2268-2280, 2020	697	2020
Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk T Bhattacharyya, SJ Nicholls, EJ Topol, R Zhang, X Yang, D Schmitt, X Fu, ... Jama 299 (11), 1265-1276, 2008	652	2008
Association of triglyceride-lowering LPL variants and LDL-C–lowering LDLR variants with risk of coronary heart disease BA Ference, JJP Kastelein, KK Ray, HN Ginsberg, MJ Chapman, ... Jama 321 (4), 364-373, 2019	595	2019

Sistem trenutno ne more izvesti postopka. Poskusite znova pozneje.

Članki 1–20

Št. navedb na leto

Podvojene navedbe

Združene navedbe

Dodajanje soavtorjevSoavtorji

Spremljaj

Navedeno

Soavtorji